← Eichor
Study identifier: NCT06867289 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring

Condition: Procedural Sedation and Analgesia · Pediatric ALL  ·  Sponsor: Centre Hospitalier Régional Metz-Thionville

PhaseNA
Planned participants50
Who can joinAll sexes, 1 Year to 18 Years
Healthy volunteersNo

About this study

This is a prospective, monocentric diagnostic study aiming to evaluate whether a sedation score obtained by a per-procedural electroencephalogram (EEG), the PSI score, could identify patients for whom a 2 μg/kg dose of DEX would not be sufficient for the successful performance of cerebral NMRI, and who could therefore benefit from a higher dosage of DEX (4 μg/kg).

This description comes directly from the study's public registry record.

Talk to the study team

Arpiné EL NAR, PhD  ·  0033387557766  ·  projet-recherche-clinique@chr-metz-thionville.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHR Metz-Thionville Hopital Femme-Mère EnfantMetz, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06867289